ICON PLC (ICLR) Stock Analysis

ICON PLC (ICLR) is a publicly traded company in the HEALTHCARE sector. It trades at $137.54, carries a market capitalization of $10.57B, a price-to-earnings ratio of 47.60. This page summarizes the public market data, fundamentals, and frequently asked questions for ICLR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $137.54
• Market Cap: $10.57B
• P/E Ratio: 47.60
• EPS: $2.90
• 52-Week High: $211.00
• 52-Week Low: $66.57

Market Sentiment

ICON PLC currently has a Neutral sentiment score of 0.03.

About ICON PLC

ICON Public Limited Company is a premier global clinical research organization (CRO) based in Dublin, Ireland, dedicated to delivering comprehensive outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device sectors. With a robust operational footprint across Europe, the United States, and other key markets, ICON excels in optimizing clinical trials, regulatory compliance, and market access strategies, enhancing client efficiencies in drug d...

GNG Research Analysis

GNG Research scores ICON PLC (ICLR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ICLR.

Frequently Asked Questions

Does ICLR pay dividends?

ICON PLC (ICLR) does not currently pay a regular dividend.

What is ICLR's P/E ratio?

ICON PLC has a price-to-earnings (P/E) ratio of 47.60.

What is ICLR's market cap?

ICON PLC (ICLR) has a market capitalization of $10.57B with a current stock price of $137.54.